301230 泓博医药
已收盘 06-01 15:00:00
资讯
新帖
简况
泓博医药（301230）披露2024年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告，5月28日股价上涨0.36%
证券之星 · 05-28
泓博医药（301230）披露2024年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告，5月28日股价上涨0.36%
泓博医药（301230）披露2025年度持续督导定期现场检查报告，5月19日股价上涨1.21%
证券之星 · 05-19
泓博医药（301230）披露2025年度持续督导定期现场检查报告，5月19日股价上涨1.21%
股市必读：泓博医药(301230)股东户数2.29万户，较上期增加0.81%
证券之星 · 05-18
股市必读：泓博医药(301230)股东户数2.29万户，较上期增加0.81%
泓博医药（301230）披露2025年度网上业绩说明会公告，5月15日股价下跌3.14%
证券之星 · 05-15
泓博医药（301230）披露2025年度网上业绩说明会公告，5月15日股价下跌3.14%
泓博医药：截至2026年5月8日股东户数为22,920户
证券之星 · 05-15
泓博医药：截至2026年5月8日股东户数为22,920户
5月14日泓博医药跌7.41%，长城消费增值混合A基金重仓该股
证券之星 · 05-14
5月14日泓博医药跌7.41%，长城消费增值混合A基金重仓该股
泓博医药（301230）披露关于认购基金份额暨关联交易并完成工商变更登记的公告，5月7日股价上涨2.61%
证券之星 · 05-07
泓博医药（301230）披露关于认购基金份额暨关联交易并完成工商变更登记的公告，5月7日股价上涨2.61%
每周股票复盘：泓博医药（301230）Q1净利增98.59%
证券之星 · 05-03
每周股票复盘：泓博医药（301230）Q1净利增98.59%
图解泓博医药一季报：第一季度单季净利润同比增长98.59%
证券之星 · 04-29
图解泓博医药一季报：第一季度单季净利润同比增长98.59%
4月22日泓博医药涨9.80%，长城消费增值混合A基金重仓该股
证券之星 · 04-22
4月22日泓博医药涨9.80%，长城消费增值混合A基金重仓该股
股市必读：泓博医药(301230)股东户数2.39万户，较上期减少4.36%
证券之星 · 04-20
股市必读：泓博医药(301230)股东户数2.39万户，较上期减少4.36%
泓博医药：截至2026年4月10日股东户数为23,935户
证券之星 · 04-17
泓博医药：截至2026年4月10日股东户数为23,935户
泓博医药：公司与药石科技未开展相关合作
证券日报网 · 04-03
泓博医药：公司与药石科技未开展相关合作
泓博医药：截至2026年3月31日股东户数为25,026户
中金财经 · 04-03
泓博医药：截至2026年3月31日股东户数为25,026户
4月3日泓博医药跌7.58%，长城消费增值混合A基金重仓该股
证券之星 · 04-03
4月3日泓博医药跌7.58%，长城消费增值混合A基金重仓该股
4月1日泓博医药涨7.83%，长城消费增值混合A基金重仓该股
证券之星 · 04-01
4月1日泓博医药涨7.83%，长城消费增值混合A基金重仓该股
3月30日泓博医药涨6.86%，长城消费增值混合A基金重仓该股
证券之星 · 03-30
3月30日泓博医药涨6.86%，长城消费增值混合A基金重仓该股
3月27日泓博医药涨5.52%，长城消费增值混合A基金重仓该股
证券之星 · 03-27
3月27日泓博医药涨5.52%，长城消费增值混合A基金重仓该股
泓博医药：截至2026年3月20日股东户数为19,571户
证券之星 · 03-24
泓博医药：截至2026年3月20日股东户数为19,571户
彩讯股份：公司暂未与泓博医药合作
证券之星 · 03-18
彩讯股份：公司暂未与泓博医药合作
加载更多
公司概况
公司名称：
上海泓博智源医药股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-11-01
主营业务：
上海泓博智源医药股份有限公司的主营业务是药物发现、制药工艺的研究开发以及原料药中间体的商业化生产。公司的主要产品是药物化学、合成化学、药物代谢动力学、工艺化学、工艺开发、药学研究、定制化生产、自主产品生产。
发行价格：
40.00
{"stockData":{"symbol":"301230","market":"SZ","secType":"STK","nameCN":"泓博医药","latestPrice":35.61,"timestamp":1780297395000,"preClose":35.34,"halted":0,"volume":5247764,"delay":0,"changeRate":0.0076,"floatShares":126000000,"shares":140000000,"eps":0.3303,"marketStatus":"已收盘","change":0.27,"latestTime":"06-01 15:00:00","open":35.87,"high":36.41,"low":34.63,"amount":188000000,"amplitude":0.0504,"askPrice":35.61,"askSize":24,"bidPrice":35.6,"bidSize":183,"shortable":0,"etf":0,"ttmEps":0.3303,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780363800000},"marketStatusCode":5,"adr":0,"adjPreClose":35.34,"symbolType":"stock","openAndCloseTimeList":[[1780277400000,1780284600000],[1780290000000,1780297200000]],"highLimit":38.87,"lowLimit":31.81,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":139586605,"isCdr":false,"pbRate":4.79,"roa":"--","peRate":107.811081,"roe":"2.34%","epsLYR":0.25,"committee":0.481013,"marketValue":4971000000,"turnoverRate":0.0418,"status":0,"floatMarketCap":4473000000},"requestUrl":"/m/hq/s/301230","defaultTab":"news","newsList":[{"id":"2638914706","title":"泓博医药（301230）披露2024年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告，5月28日股价上涨0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638914706","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638914706?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:27","pubTimestamp":1779978433,"startTime":"0","endTime":"0","summary":"近日，上海泓博智源医药股份有限公司发布《关于2024年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告》。公告显示，公司于2026年5月28日完成2024年限制性股票激励计划首次授予部分第一个归属期的股份归属登记，本次归属日为2026年5月28日，归属股票数量为308,000股，归属对象为23名激励对象，股票来源为公司从二级市场回购的A股普通股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800043278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636834738","title":"泓博医药（301230）披露2025年度持续督导定期现场检查报告，5月19日股价上涨1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636834738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636834738?lang=zh_cn&edition=full","pubTime":"2026-05-19 17:33","pubTimestamp":1779183189,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，泓博医药报收于39.32元，较前一交易日上涨1.21%，最新总市值为54.89亿元。该股当日开盘38.97元，最高39.87元，最低38.89元，成交额达1.65亿元，换手率为3.33%。公告显示，中信证券对泓博医药2025年度持续督导进行了现场检查，检查期间为2025年1月1日至12月31日，现场检查时间为2026年5月12日。现场检查未发现重大问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900032656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636013316","title":"股市必读：泓博医药(301230)股东户数2.29万户，较上期增加0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636013316","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636013316?lang=zh_cn&edition=full","pubTime":"2026-05-18 01:32","pubTimestamp":1779039132,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，泓博医药报收于39.22元，下跌3.14%，换手率5.33%，成交量6.7万手，成交额2.68亿元。股本股东变化股东户数变动近日泓博医药披露，截至2026年5月8日公司股东户数为2.29万户，较4月30日增加185.0户，增幅为0.81%。户均持股数量由上期的6140.0股减少至6090.0股，户均持股市值为25.97万元。公司公告汇总关于举行2025年度网上业绩说明会的公告上海泓博智源医药股份有限公司已于2026年4月29日披露《2025年年度报告》及摘要。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800000653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635038798","title":"泓博医药（301230）披露2025年度网上业绩说明会公告，5月15日股价下跌3.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635038798","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635038798?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:14","pubTimestamp":1778854464,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，泓博医药报收于39.22元，较前一交易日下跌3.14%，最新总市值为54.75亿元。公司于近日披露《关于举行2025年度网上业绩说明会的公告》。公告显示，上海泓博智源医药股份有限公司已于2026年4月29日披露《2025年年度报告》及摘要。公司将于2026年5月22日15:00-16:00在全景网举行2025年度网上业绩说明会，投资者可通过全景网“投资者关系互动平台”参与。公司现面向投资者提前征集问题，征集截止时间为2026年5月21日15:00。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500044010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635784287","title":"泓博医药：截至2026年5月8日股东户数为22,920户","url":"https://stock-news.laohu8.com/highlight/detail?id=2635784287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635784287?lang=zh_cn&edition=full","pubTime":"2026-05-15 09:15","pubTimestamp":1778807733,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药(301230)05月14日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问截止至2026年5月10日收盘公司股东人数为多少，谢谢！泓博医药回复：尊敬的投资者您好！根据中登公司下发的股东名册，截至2026年5月8日（交易日），公司的股东户数为22,920户。感谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500009568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635479242","title":"5月14日泓博医药跌7.41%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635479242","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635479242?lang=zh_cn&edition=full","pubTime":"2026-05-14 16:42","pubTimestamp":1778748147,"startTime":"0","endTime":"0","summary":"证券之星消息，5月14日泓博医药跌7.41%，收盘报40.49元，换手率6.9%，成交量8.66万手，成交额3.67亿元。重仓泓博医药的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为5.33亿元，最新净值1.1879，较上一交易日上涨0.92%，近一年上涨9.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400028876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633125621","title":"泓博医药（301230）披露关于认购基金份额暨关联交易并完成工商变更登记的公告，5月7日股价上涨2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633125621","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633125621?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:58","pubTimestamp":1778147933,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，泓博医药报收于43.63元，较前一交易日上涨2.61%，最新总市值为60.9亿元。近日，泓博医药发布《关于认购基金份额暨关联交易并完成工商变更登记的公告》。该基金主要投资于生物医药健康产业，公司与普通合伙人及其他有限合伙人已签署合伙协议，并完成工商变更登记。本次投资构成与关联方开原亨泰营养科技有限公司的共同投资，属于关联交易，已履行董事会审议程序，无需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700030474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632367461","title":"每周股票复盘：泓博医药（301230）Q1净利增98.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632367461","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632367461?lang=zh_cn&edition=full","pubTime":"2026-05-03 03:01","pubTimestamp":1777748474,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，泓博医药报收于41.4元，较上周的43.36元下跌4.52%。本周关注点业绩披露要点：泓博医药2026年一季度归母净利润同比增长98.59%。股本股东变化截至2026年4月10日，泓博医药股东户数为2.39万户，较3月31日减少1091.0户，减幅为4.36%。预计派发现金股利约27,508,081元（含税），转增后总股本增至180,848,726股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631532389","title":"图解泓博医药一季报：第一季度单季净利润同比增长98.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631532389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631532389?lang=zh_cn&edition=full","pubTime":"2026-04-29 06:17","pubTimestamp":1777414639,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药2026年一季报显示，一季度公司主营收入1.72亿元，同比上升1.69%；归母净利润2377.92万元，同比上升98.59%；扣非净利润645.66万元，同比下降33.32%；负债率21.73%，投资收益680.71万元，财务费用374.47万元，毛利率31.92%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900014775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629201540","title":"4月22日泓博医药涨9.80%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629201540","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629201540?lang=zh_cn&edition=full","pubTime":"2026-04-22 16:34","pubTimestamp":1776846897,"startTime":"0","endTime":"0","summary":"证券之星消息，4月22日泓博医药涨9.80%，收盘报43.82元，换手率11.11%，成交量13.96万手，成交额5.76亿元。重仓泓博医药的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为4.74亿元，最新净值1.1122，较上一交易日下跌1.16%，近一年上涨10.67%。该公募基金现任基金经理为龙宇飞。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200037904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628798976","title":"股市必读：泓博医药(301230)股东户数2.39万户，较上期减少4.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628798976","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628798976?lang=zh_cn&edition=full","pubTime":"2026-04-20 01:37","pubTimestamp":1776620227,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，泓博医药报收于40.06元，下跌2.36%，换手率5.56%，成交量6.99万手，成交额2.8亿元。股本股东变化股东户数变动近日泓博医药披露，截至2026年4月10日公司股东户数为2.39万户，较3月31日减少1091.0户，减幅为4.36%。户均持股数量由上期的5578.0股增加至5832.0股，户均持股市值为23.25万元。根据中登公司下发的股东名册，截至2026年4月10日（交易日），公司的股东户数为23,935户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000000807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628796282","title":"泓博医药：截至2026年4月10日股东户数为23,935户","url":"https://stock-news.laohu8.com/highlight/detail?id=2628796282","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628796282?lang=zh_cn&edition=full","pubTime":"2026-04-17 16:24","pubTimestamp":1776414264,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药(301230)04月17日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年4月15日收盘公司股东人数是多少？谢谢！泓博医药回复：尊敬的投资者您好！根据中登公司下发的股东名册，截至2026年4月10日（交易日），公司的股东户数为23,935户。感谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700030461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624657429","title":"泓博医药：公司与药石科技未开展相关合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2624657429","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624657429?lang=zh_cn&edition=full","pubTime":"2026-04-03 19:38","pubTimestamp":1775216280,"startTime":"0","endTime":"0","summary":"证券日报网讯4月3日，泓博医药在互动平台回答投资者提问时表示，截至目前，公司与药石科技未开展相关合作。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-04-03/doc-inhtfrev3672977.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-04-03/doc-inhtfrev3672977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0229","300725","301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624656576","title":"泓博医药：截至2026年3月31日股东户数为25,026户","url":"https://stock-news.laohu8.com/highlight/detail?id=2624656576","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624656576?lang=zh_cn&edition=full","pubTime":"2026-04-03 16:54","pubTimestamp":1775206443,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药(301230)04月03日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年3月31日公司股东人数是多少？谢谢！泓博医药回复：尊敬的投资者您好！根据中登公司下发的股东名册，截至2026年3月31日(交易日)，公司的股东户数为25,026户。感谢关注！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260403/32124756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624765514","title":"4月3日泓博医药跌7.58%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624765514","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624765514?lang=zh_cn&edition=full","pubTime":"2026-04-03 16:17","pubTimestamp":1775204275,"startTime":"0","endTime":"0","summary":"证券之星消息，4月3日泓博医药跌7.58%，收盘报40.99元，换手率11.85%，成交量14.89万手，成交额6.25亿元。重仓泓博医药的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为4.74亿元，最新净值1.1331，较上一交易日下跌0.99%，近一年上涨2.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300031342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624330595","title":"4月1日泓博医药涨7.83%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624330595","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624330595?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:19","pubTimestamp":1775031553,"startTime":"0","endTime":"0","summary":"证券之星消息，4月1日泓博医药涨7.83%，收盘报43.79元，换手率18.03%，成交量22.65万手，成交额9.51亿元。重仓泓博医药的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为4.74亿元，最新净值1.0955，较上一交易日下跌1.32%，近一年上涨0.87%。该公募基金现任基金经理为龙宇飞。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100029177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623239700","title":"3月30日泓博医药涨6.86%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623239700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623239700?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:29","pubTimestamp":1774859381,"startTime":"0","endTime":"0","summary":"证券之星消息，3月30日泓博医药涨6.86%，收盘报39.43元，换手率14.65%，成交量18.41万手，成交额7.35亿元。重仓泓博医药的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为4.74亿元，最新净值1.102，较上一交易日上涨2.52%，近一年上涨0.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000021618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622361849","title":"3月27日泓博医药涨5.52%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622361849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622361849?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:18","pubTimestamp":1774599508,"startTime":"0","endTime":"0","summary":"证券之星消息，3月27日泓博医药涨5.52%，收盘报36.9元，换手率5.08%，成交量6.38万手，成交额2.31亿元。重仓泓博医药的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为4.74亿元，最新净值1.0749，较上一交易日下跌1.65%，近一年下跌2.1%。该公募基金现任基金经理为龙宇飞。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700033494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621059046","title":"泓博医药：截至2026年3月20日股东户数为19,571户","url":"https://stock-news.laohu8.com/highlight/detail?id=2621059046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621059046?lang=zh_cn&edition=full","pubTime":"2026-03-24 15:15","pubTimestamp":1774336524,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药(301230)03月24日在投资者关系平台上答复投资者关心的问题。投资者提问：公司最新股东人数泓博医药回复：尊敬的投资者您好！根据中登公司下发的股东名册，截至2026年3月20日（交易日），公司的股东户数为19,571户。感谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400019846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620316172","title":"彩讯股份：公司暂未与泓博医药合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2620316172","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620316172?lang=zh_cn&edition=full","pubTime":"2026-03-18 17:48","pubTimestamp":1773827300,"startTime":"0","endTime":"0","summary":"证券之星消息，彩讯股份(300634)03月18日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，注意到公司在布局AI制药相关方面，也注意到公司在和泓博医药有AI制药AI大模型相关的合作，泓博医药可以说是国内AI制药第一股，现在市值这么低潜力这么巨大，公司为什么不直接控股或者收购呢彩讯股份回复：尊敬的投资者，您好！公司暂未与泓博医药合作，暂无上述安排，请以公司公告为准。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800032428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216","300634","BK0231"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780333763226,"stockEarnings":[{"period":"1week","weight":-0.0569},{"period":"1month","weight":-0.1399},{"period":"3month","weight":-0.0953},{"period":"6month","weight":0.1832},{"period":"1year","weight":0.1129},{"period":"ytd","weight":0.1947}],"compareEarnings":[{"period":"1week","weight":-0.0228},{"period":"1month","weight":-0.0132},{"period":"3month","weight":-0.0158},{"period":"6month","weight":0.0463},{"period":"1year","weight":0.2122},{"period":"ytd","weight":0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海泓博智源医药股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"22920人(较上一季度增加0.81%)","perCapita":"5480股","listingDate":"2022-11-01","address":"上海市浦东新区庆达路315号23幢","registeredCapital":"13958万元","survey":" 上海泓博智源医药股份有限公司的主营业务是药物发现、制药工艺的研究开发以及原料药中间体的商业化生产。公司的主要产品是药物化学、合成化学、药物代谢动力学、工艺化学、工艺开发、药学研究、定制化生产、自主产品生产。","listedPrice":40},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泓博医药(301230)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泓博医药(301230)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泓博医药,301230,泓博医药股票,泓博医药股票老虎,泓博医药股票老虎国际,泓博医药行情,泓博医药股票行情,泓博医药股价,泓博医药股市,泓博医药股票价格,泓博医药股票交易,泓博医药股票购买,泓博医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泓博医药(301230)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泓博医药(301230)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}